MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
headlines news headlines   email email to a friend   printer printer friendly   newsletter sign up to newsletter  

NICE Guidance Recommends Option For Preventing Arterial Blood Clots In People With Acute Coronary Syndromes

Main Category: Cardiovascular / Cardiology
Also Included In: Blood / Hematology | Heart Disease
Article Date: 03 Nov 2009

The National Institute for Health and Clinical Excellence (NICE) has published final guidance recommending the use of prasugrel in combination with aspirin as an option for preventing blood clots in the arteries of people with acute coronary syndromes. Acute coronary syndromes refers to a group of heart problems which occur due to narrowed coronary arteries. These heart problems cause chest pain, and specific types of heart attack. Prasugrel is a drug that can reduce or prevent the formation of blood clots in arteries by reducing the clumping together of platelets in the blood.

The guidance recommends prasugrel in combination with aspirin as an option for individuals who are having percutaneous coronary intervention, only when:

immediate primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction (a specific type of heart attack) is necessary or a blood clot blocking a stent has occurred during treatment with a drug called clopidogrel or the patient has diabetes mellitus.People currently receiving prasugrel for treatment of acute coronary syndromes whose circumstances do not meet these criteria should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

Dr Carole Longson, Director at NICE said: "There are a range of heart problems classed as acute coronary syndromes - these conditions have a huge impact on the individuals affected. This new guidance recommending prasugrel in combination with aspirin will offer an additional treatment option for these specific individuals at risk of blood clots."

Source
NICE

Original article posted on Medical News Today.
Articles not to be reproduced without permission of Medical News Today

Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles.





For any corrections of factual information, or to contact the editors please use our feedback form.
Send your press releases to








free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.